The National Institutes of Health have announced a clinical trial for the investigational vaccine for COVID-19, or Corona-virus. Currently, the study is enrolling healthy Seattle-based adult volunteers. The first participant received the investigational vaccine Monday, March 16th.
The study is evaluating different doses of the experimental vaccine for safety. Additionally, its ability to induce an immune response in participants is also being looked at. Because this is the first of multiple steps in the clinical trial process, experts are evaluating the potential benefit of the vaccine.
According to the People for the Ethical Treatment of Animals, the COVID-19 vaccine will skip animal trials and go directly to human testing! This is huge for humans and animals!
The hope is that we will have a corona-virus vaccine in 12-18 months.
Infection with SARS-CoV-2, the virus that causes COVID-19, can cause a mild to severe respiratory illness. Additionally, other symptoms may include fever, cough and shortness of breath.
Furthermore, as of March 18, 2020, the Centers for Disease and Control has reported over 7,000 cases of COVID-19 in the U.S.